TH1501007670A - Use of semaphorin-4D inhibitory molecules in combination with immune-modifying therapeutic agents to inhibit tumor growth. and the spread of tumors (metastases) - Google Patents

Use of semaphorin-4D inhibitory molecules in combination with immune-modifying therapeutic agents to inhibit tumor growth. and the spread of tumors (metastases)

Info

Publication number
TH1501007670A
TH1501007670A TH1501007670A TH1501007670A TH1501007670A TH 1501007670 A TH1501007670 A TH 1501007670A TH 1501007670 A TH1501007670 A TH 1501007670A TH 1501007670 A TH1501007670 A TH 1501007670A TH 1501007670 A TH1501007670 A TH 1501007670A
Authority
TH
Thailand
Prior art keywords
semaphorin
metastases
tumors
immune
spread
Prior art date
Application number
TH1501007670A
Other languages
Thai (th)
Other versions
TH179097A (en
Inventor
เอสสมิธ มัวไรซ์ เซาเดอเรอร์ เอซิซาเบธ อี อีวานส์ เออร์เนสท์
Original Assignee
วัคซิเน็กซ์ อิงค์
Filing date
Publication date
Application filed by วัคซิเน็กซ์ อิงค์ filed Critical วัคซิเน็กซ์ อิงค์
Publication of TH1501007670A publication Critical patent/TH1501007670A/en
Publication of TH179097A publication Critical patent/TH179097A/en

Links

Abstract

; ;

TH1501007670A 2014-06-20 The use of semaphorin-inhibiting molecules (semaphorin-4D) in combination with immunosuppressive agents to suppress tumor growth. And metastases TH179097A (en)

Publications (2)

Publication Number Publication Date
TH1501007670A true TH1501007670A (en) 2018-08-23
TH179097A TH179097A (en) 2018-08-23

Family

ID=

Similar Documents

Publication Publication Date Title
BR112017006664A2 (en) combination therapies
EA201892386A1 (en) Chimeric neurotoxins
ECSP15026557A (en) COMPOUNDS AND THEIR METHODS OF USE
DK3212670T3 (en) COMBINATION THERAPY AGAINST CANCER
DK3142637T3 (en) KERATIN TREATMENT FORMULATIONS AND METHODS
DK3134125T3 (en) Antibody-drug conjugate and its use in the treatment of cancer
BR112017002232A2 (en) bruton tyrosine kinase inhibitor combinations and uses thereof
IL276733A (en) Use of eribulin in the treatment of cancer
DK3439663T3 (en) ADVANCES IN THE TREATMENT OF PEDIATRIC CANCER
BR112016017112A2 (en) APILIMOD COMPOSITIONS AND METHODS OF USE THEREOF
DK3532067T3 (en) LIPOSOMAL FORMULATION FOR USE IN THE TREATMENT OF CANCER
CL2015002897A1 (en) Bace1 inhibitors
DK3374497T3 (en) MODIFIED MACROPHAGE FOR USE IN THE TREATMENT OF CANCER
BR112017008799A2 (en) apilimod compositions and methods of use in treating kidney cancer
DK3302519T3 (en) ORNITHODOROS-MOUBATA-COMPLEMENT-INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
TR201901348T4 (en) Pyrrolidinone derivatives as metap-2 inhibitors.
DK3253208T3 (en) Combination therapies for use in the treatment of breast cancer
DK3606926T3 (en) HETEROAROMATIC COMPOUNDS USE IN THERAPY
DK3164123T3 (en) Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
DK3463436T3 (en) VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN THE TREATMENT OF CANCER
DK2988760T3 (en) C. NOVYI FOR THE TREATMENT OF FIXED TUMORS IN HUMANS
ES2985036T3 (en) Methods and compositions for the treatment of cancer
PH12016501838A1 (en) Compounds and their methods of use
DK3383872T3 (en) 1,3,4-THIADIAZOLIC COMPOUNDS AND ITS USE IN CANCER TREATMENT
DE112015002229A5 (en) Formulations for the treatment of hyperthyroidism